Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Nagumo A

Collect these papers and discover other ones on Labmeeting. Learn more.

Identification and characterization of a selective radioligand for ELOVL6.

+ cite this

+ View Abstract

Shimamura K, Takahashi H, Kitazawa H, Miyamoto Y, Nagumo A, Tang C, Dean D, Nagase T, Sato N, and Tokita S

Journal of biochemistry 146(3):429-37, 2009 Sep - Who cited this? | PubMed ID: 19505953 | Fulltext

Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.

+ cite this

+ View Abstract

Sasaki T, Nagase T, Takahashi T, Nagumo A, Shimamura K, Miyamoto Y, Kitazawa H, Kanesaka M, Yoshimoto R, Aragane K, Tokita S, and Sato N

Bioorganic & medicinal chemistry 17(15):5639-47, 2009 Aug 1 - Who cited this? | PubMed ID: 19596583 | Fulltext

Development of a High-Density Assay for Long-Chain Fatty Acyl-CoA Elongases.

+ cite this

+ View Abstract

Kitazawa H, Miyamoto Y, Shimamura K, Nagumo A, and Tokita S

Lipids 44(8):765-73, 2009 Aug - Who cited this? | PubMed ID: 19575253 | Fulltext

Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.

+ cite this

+ View Abstract

Nagase T, Takahashi T, Sasaki T, Nagumo A, Shimamura K, Miyamoto Y, Kitazawa H, Kanesaka M, Yoshimoto R, Aragane K, Tokita S, and Sato N

Journal of medicinal chemistry 52(14):4111-4, 2009 Jul 23 - Who cited this? | PubMed ID: 19522500 | Fulltext

5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a Potent Inhibitor for Mammalian Elongase of Long-Chain Fatty Acids Family 6: Examination of Its Potential Utility as a Pharmacological Tool.

+ cite this

+ View Abstract

Shimamura K, Kitazawa H, Miyamoto Y, Kanesaka M, Nagumo A, Yoshimoto R, Aragane K, Morita N, Ohe T, Takahashi T, Nagase T, Sato N, and Tokita S

The Journal of pharmacology and experimental therapeutics 330(1):249-56, 2009 Jul - Who cited this? | PubMed ID: 19359527 | Fulltext

Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.

+ cite this

+ View Abstract

Takahashi T, Nagase T, Sasaki T, Nagumo A, Shimamura K, Miyamoto Y, Kitazawa H, Kanesaka M, Yoshimoto R, Aragane K, Tokita S, and Sato N

Journal of medicinal chemistry 52(10):3142-5, 2009 May 28 - Who cited this? | PubMed ID: 19388647 | Fulltext

Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy.

+ cite this

+ View Abstract

Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, Kikuchi-Taura A, Soma T, Taguchi A, and Yoshimasa Y

Diabetic medicine : a journal of the British Diabetic Association 26(2):171-3, 2009 Feb - Who cited this? | PubMed ID: 19236621 | Fulltext

Pioglitazone treatment stimulates circulating CD34-positive cells in type 2 diabetes patients.

+ cite this

+ View Abstract

Makino H, Okada S, Nagumo A, Sugisawa T, Miyamoto Y, Kishimoto I, Akie TK, Soma T, Taguchi A, and Yoshimasa Y

Diabetes research and clinical practice 81(3):327, 2008 Sep - Who cited this? | PubMed ID: 18639363 | Fulltext

Circulating CD34-Positive Cell Number Is Associated With Brain Natriuretic Peptide Level in Type 2 Diabetic Patients.

+ cite this

Okada S, Makino H, Nagumo A, Sugisawa T, Fujimoto M, Kishimoto I, Miyamoto Y, Kikuchi-Taura A, Soma T, Taguchi A, and Yoshimasa Y

Diabetes care 31(1):157-8, 2008 Jan - Who cited this? | PubMed ID: 17959862 | Fulltext

Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria.

+ cite this

+ View Abstract

Makino H, Doi K, Hiuge A, Nagumo A, Okada S, Miyamoto Y, Suzuki M, and Yoshimasa Y

Diabetes research and clinical practice 79(1):177-82, 2008 Jan - Who cited this? | PubMed ID: 17904244 | Fulltext

[Familial hypercholesterolemia (FH)].

+ cite this

Harada-Shiba M and Nagumo A

Nippon rinsho. Japanese journal of clinical medicine 65 Suppl 7:295-300, 2007 Jul 28 - Who cited this? | PubMed ID: 17824048 | Fulltext

A reversed tibial flip autograft technique for correcting over-valgus knee after high tibial closing-wedge osteotomy in total knee arthroplasty.

+ cite this

+ View Abstract

Nagumo A, Ishibashi Y, Tsuda E, and Toh S

The Journal of arthroplasty 21(5):771-4, 2006 Aug - Who cited this? | PubMed ID: 16877168 | Fulltext

In vitro elution of vancomycin from calcium phosphate cement.

+ cite this

+ View Abstract

Sasaki T, Ishibashi Y, Katano H, Nagumo A, and Toh S

The Journal of arthroplasty 20(8):1055-9, 2005 Dec - Who cited this? | PubMed ID: 16376263 | Fulltext

Effects of separate application of three growth factors (TGF-beta1, EGF, and PDGF-BB) on mechanical properties of the in situ frozen-thawed anterior cruciate ligament.

+ cite this

+ View Abstract

Nagumo A, Yasuda K, Numazaki H, Azuma H, Tanabe Y, Kikuchi S, Harata S, and Tohyama H

Clinical biomechanics (Bristol, Avon) 20(3):283-90, 2005 Mar - Who cited this? | PubMed ID: 15698701 | Fulltext

Effects of combined administration of transforming growth factor-beta1 and epidermal growth factor on properties of the in situ frozen anterior cruciate ligament in rabbits.

+ cite this

+ View Abstract

Sakai T, Yasuda K, Tohyama H, Azuma H, Nagumo A, Majima T, and Frank CB

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20(6):1345-51, 2002 Nov - Who cited this? | PubMed ID: 12472251 | Fulltext

An occult fracture of the trapezoid bone. A case report.

+ cite this

Nagumo A, Toh S, Tsubo K, Ishibashi Y, and Sasaki T

The Journal of bone and joint surgery. American volume 84-A(6):1025-7, 2002 Jun - Who cited this? | PubMed ID: 12063340 | Fulltext

Purification and characterization of recombinant squalene epoxidase.

+ cite this

+ View Abstract

Nagumo A, Kamei T, Sakakibara J, and Ono T

Journal of lipid research 36(7):1489-97, 1995 Jul - Who cited this? | PubMed ID: 7595073 | Fulltext

Effect of bacteriohopane-32-ol on lipid metabolism in Hep G2 cells.

+ cite this

+ View Abstract

Nagumo A, Ishida F, Kamei T, and Suzuki Y

Chemical & pharmaceutical bulletin 40(5):1332-4, 1992 May - Who cited this? | PubMed ID: 1394657 | Fulltext

Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro.

+ cite this

+ View Abstract

Nagumo A, Takanashi K, Hojo H, and Suzuki Y

Toxicology letters 58(3):309-13, 1991 Nov - Who cited this? | PubMed ID: 1957326 | Fulltext

[The effectiveness of CDDP in metastatic adenocarcinoma with unknown origin].

+ cite this

+ View Abstract

Hara T, Ogawa M, Mukai T, Watanabe Y, Ishii M, Nagumo A, Taguchi S, and Hatta Y

Gan to kagaku ryoho. Cancer & chemotherapy 18(4):649-52, 1991 Apr - Who cited this? | PubMed ID: 2012404 | Fulltext

[Changes in Y-protein and ligandin in human liver tumor tissues].

+ cite this

+ View Abstract

Hirose N, Nagumo A, Funatomi H, Taguchi S, Takeda M, and Hatta Y

Gan no rinsho. Japan journal of cancer clinics 31(10):1247-52, 1985 Aug - Who cited this? | PubMed ID: 2997496 | Fulltext

[The pancreas and disseminated intravascular coagulation].

+ cite this

Hatta Y, Usui M, Nagumo A, Shin S, Funatomi H, and Taguchi S

Rinsho byori. The Japanese journal of clinical pathology Spec No 63:141-8, 1985 Jun - Who cited this? | PubMed ID: 3900482 | Fulltext

[Preparation of anti-lipid A antibody and evaluation of its specificity].

+ cite this

Kasai N, Nagumo A, Satomi T, Mashita J, and Okubo S

Nippon saikingaku zasshi. Japanese journal of bacteriology 30(1):179, 1975 Jan - Who cited this? | PubMed ID: 1240222 | Fulltext

Search Google Scholar for Nagumo A

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!